The Saudi Thoracic Society evidence-based guidelines for the diagnosis and management of community-acquired pneumonia in children and adults
Annals of Thoracic Medicine · 2025-10 · 20 (4) · 195-212
DOI: 10.4103/atm.atm_293_25 ↗Kurz gefasst
Leitlinie in der Zeitschrift Annals of Thoracic Medicine, online erschienen am 20.10.2025. Verfasst von Sami Mohammed A Alyami und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Pulmonary Division, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in children and adults. The burden is especially high among older adults and those with comorbidities. It is also the leading cause of hospital admissions during the annual Islamic pilgrimage (Hajj). CAP is a heterogeneous illness, varying in both etiology and clinical course across different patients. The Saudi Thoracic Society (STS) has developed evidence-based guidelines for the diagnosis, management, and prevention of CAP in both adult and pediatric populations in Saudi Arabia. This is the first guideline of its kind to combine both patient populations in one guideline. Although data on various aspects of CAP – especially within Saudi Arabia – remain limited, the task force based its recommendations on the best available evidence and a structured voting process to answer preset clinical questions. Main highlights from the guidelines include that routine complete blood count may assist in guiding management, particularly in severe disease, while acute-phase reactants (C-reactive protein, procalcitonin) are not recommended at initial diagnosis but may be useful if patients fail to improve. Blood cultures and sputum Gram stain/culture should not be routinely performed, except in severe or deteriorating cases or in hospitalized patients. Respiratory testing for viral pathogens and atypical bacteria is suggested when clinically indicated, especially during outbreaks or in high-risk groups. Chest radiography is recommended in adults and hospitalized children. Short-course antibiotic therapy is favored for improving patients, with early transition from intravenous to oral therapy when hospitalized. Macrolides are preferred over fluoroquinolones in outpatients, while combination beta-lactam plus macrolide therapy is recommended for inpatients. Preventive measures, particularly vaccination, are strongly endorsed. Special considerations apply to elderly, pregnant, chronic obstructive pulmonary disease, and immunocompromised patients. Corticosteroids may benefit select severe cases but are not recommended routinely. These guidelines are intended primarily for general practitioners, emergency physicians, pediatricians, and internal medicine specialists. To enhance accessibility and implementation, STS has simplified the guidelines and provided an executive summary of the key recommendations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Pulmonary Division, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia.
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
- Department of Pediatric Infectious Diseases, Children's Hospital, King Saud Medical City, Riyadh, Saudi Arabia.
- Department of Medical Protocols, Internal Medicine Section, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
- Director of Infection Prevention and Control Program, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia.
Zitieren
APA
Alyami, S. M. A., Alzomor, O., Hassan, I. S., AlShamrani, M., Al-Jazairi, A. S., Algamdi, M., Bahabri, N., Alahmadi, T. S., Tashkandi, N. A., Alkhairallah, A. S., Aljindan, R., Memish, Z. A., & Alhamad, E. H. (2025). The Saudi Thoracic Society evidence-based guidelines for the diagnosis and management of community-acquired pneumonia in children and adults. Annals of Thoracic Medicine, 20(4), 195-212. https://doi.org/10.4103/atm.atm_293_25
Vancouver
Alyami SMA, Alzomor O, Hassan IS, AlShamrani M, Al-Jazairi AS, Algamdi M, et al. The Saudi Thoracic Society evidence-based guidelines for the diagnosis and management of community-acquired pneumonia in children and adults. Annals of Thoracic Medicine. 2025;20(4):195-212. doi:10.4103/atm.atm_293_25
BibTeX
@article{Alyami2025,
author = {Alyami, Sami Mohammed A and Alzomor, Omar and Hassan, Imad Salah and AlShamrani, Majid and Al-Jazairi, Abdulrazaq S and Algamdi, Mohmmed and Bahabri, Nezar and Alahmadi, Turki S and Tashkandi, Nabiha A and Alkhairallah, Amer S and Aljindan, Reem and Memish, Ziad A and Alhamad, Esam H},
title = {The Saudi Thoracic Society evidence-based guidelines for the diagnosis and management of community-acquired pneumonia in children and adults},
journal = {Annals of Thoracic Medicine},
year = {2025},
volume = {20},
number = {4},
pages = {195--212},
doi = {10.4103/atm.atm_293_25}
}
EUVIMED